PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Infinium Pharmachem Limited

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (3)

Compared with companies in India.

P/E ratio

28.6

Investors pay ₹28.6 for every ₹1 of Infinium Pharmachem Limited's yearly profit, higher than 60% of companies in India.

P/B ratio

3.68

The share price is 3.68 times Infinium Pharmachem Limited's book value per share, higher than 66% of companies in India.

Market cap

₹446 Cr

The total market value of all of Infinium Pharmachem Limited's shares at today's price (share price × number of shares), smaller than 71% of companies in India. PosiCap size class: Micro Cap.

Questions

What is Infinium Pharmachem Limited's P/E ratio?

Investors pay ₹28.6 for every ₹1 of Infinium Pharmachem Limited's yearly profit, higher than 60% of companies in India.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.